Casilda Llácer

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

Elísabeth Pérez-Ruiz, Luna Minute, Itziar Otano et al. · Nature · 2019 · 486 citations · Full text

Life Sciences, Immunology, Oncology +17

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Ángela Santonja, Alfonso Sánchez‐Muñoz, Aňa Lluch et al. · Oncotarget · 2018 · 186 citations · Full text

Medicine, Oncology, Breast Oncology +15

Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer

Rebeca Lozano, Daniela C. Salles, Shahneen Sandhu et al. · European Journal of Cancer · 2021 · 57 citations

Medicine, Oncology, Pathology +13

Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients

Begoña Jiménez, José Trigo, Bella Pajares et al. · Oral Oncology · 2012 · 47 citations

Medicine, Oncology, Pharmacotherapy +11

The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value

Alfonso Sánchez‐Muñoz, Yéssica Plata-Fernández, Margarita Fernández et al. · Clinical Breast Cancer · 2013 · 39 citations

Medicine, Oncology, Breast Oncology +15